Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.

Abstract

OBJECTIVE • To employ decision curve analysis to determine the impact of nuclear matrix protein 22 (NMP22) on clinical decision making in the detection of bladder cancer using data from a prospective trial. PATIENTS AND METHODS • The study included 1303 patients at risk for bladder cancer who underwent cystoscopy, urine cytology and measurement of urinary… (More)
DOI: 10.1111/j.1464-410X.2011.010419.x

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics